Nurs 212a - pHarm (pH) - Chapter 31: Adrenergic Blocking Agents
Settings
-
+
Focus on Nursing Pharmacology Fourth Edition by Amy M. Karch, RN, MS. Published by Lippincott Williams& Wilkins ISBN-13: 978-0-7817-9047-5 ISBN-10: 0-7817-9047-6
- 1.Drugs that block all adrenergic receptors are primarily used to treat
- A.
Respiratory conditions
- B.
Cardiac conditions
- C.
Endocrine conditions
- D.
Pain
- E.
None of the above
- 2.Adrenergic antagonists are also known as
- A.
Sympathomimetic drugs
- B.
Parasympathomimetic drugs
- C.
Narcotics
- D.
Sympatholytic drugs
- E.
Parasympatholytic drugs
- 3.Which of the following is not an indication for Labetalol?
- A.
Hypertension
- B.
Pheocrhomacytoma
- C.
Clonidine withdrawal
- D.
Congestive heart failure
- E.
None of the above
- 4.Which of the following is a contraindication for sympatholytic drugs?
- A.
Heart block
- B.
CHF
- C.
Shock
- D.
Bradycardia
- E.
All of the above
- 5.True or False:Adrenergic blocking agents competitively block the effects of acetylcholine at the alpha and beta receptors throughout the SNS
- A.
True
- B.
False
- 6.Alpha 1 selective adrenergic blocking agents do not treat
- A.
BPH
- B.
Hypertention
- C.
Angina
- D.
All of the above
- E.
None of the above
- 7.Which of the following prevents reinfarction after MI?
- A.
Alpha1-selective adrenergic blocking agents
- B.
Beta-selective adrenergic blocking agents
- C.
Alpha- and beta- adrenergic blocking agents
- D.
Cholinergic blocking agents
- E.
None of the above
- 8.Beta-adrenergic blocking agents competitively block beta receptors in
- A.
Heart
- B.
Kidney
- C.
Liver
- D.
A and B
- E.
B and C
Back to top